CrkI and p130 Cas complex regulates the migration and invasion of prostate cancer cells

Cell Biochemistry and Function

Volumn 29, Issue 8, 2011, Pages 625-629

  Dai, Yuanqing ^a   Qi, Lin ^a   Zhang, Xiaobo ^a   Li, Yuan ^a   Chen, Minfeng ^a   Zu, Xiongbing ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Activated Cdc42 associated kinase I Ack1; Cell migration; CT10 regulator of kinase I CrkI; Metastasis; P130 Cas; Prostate cancer

Indexed keywords

CRK ASSOCIATED SUBSTRATE PROTEIN; CRK LIKE PROTEIN;

ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER INVASION; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; WOUND HEALING;

CELL LINE, TUMOR; CELL MOVEMENT; CRK-ASSOCIATED SUBSTRATE PROTEIN; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; NEOPLASM INVASIVENESS; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-CRK;

EID: 83055194551     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1797     Document Type: Article

References (13)

1. Pomerantz M, Kantoff P. Advances in the treatment of prostate cancer. Annu Rev Med 2007; 58: 205-220.
2. Loblaw DA, Virgo KS, Nam R, et al. Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol 2007; 25: 1596-1605.
3. Zhao Y, Yan Q, Long X, Chen X, Wang Y. Vimentin affects the mobility and invasiveness of prostate cancer cells. Cell Biochem Function 2008; 26: 571-577.
4. Guo Z, Dai B, Jiang T, et al. Regulation of androgen receptor activity by tyrosine phosphorylation. Cancer Cell 2006; 10: 309-319.
5. Mahajan NP, Liu Y, Majumder S, et al. Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation. Proc Natl Acad Sci USA 2007; 104: 8438-8443.
6. Nishihara H, Tanaka S, Tsuda M. Molecular and immunohistochemical analysis of signaling adaptor protein Crk in human cancers. Cancer Lett 2002; 180: 55-61.
7. Takino T, Nakada M, Miyamori H, Yamashita J, Yamada KM, Sato H. CrkI adapter protein modulates cell migration and invasion in glioblastoma. Cancer Res 2003; 63: 2335-2337.
8. Coon M, Herrera R. Modulation of HeLa cells spreading by the non-receptor tyrosine kinase ACK-2. J Cell Biochem 2002; 84: 655-665.
9. Nelson EC, Evans CP, Mack PC, Devere-White RW, Lara PN, Jr. Inhibition of Akt pathways in the treatment of prostate cancer. Prostate Cancer Prostatic Dis 2007; 10: 331-339.
10. Feller SM. Crk family adaptors-signalling complex formation and biological roles. Oncogene 2001; 20: 6348-6371.
11. Kim SH, Kim SH. Antagonistic effect of EGF on FAK phosphorylation/dephosphorylation in a cell. Cell Biochem Function 2008; 26: 539-547.
12. Choi UJ, Jee BK, Lim Y, Lee KH. KAI1/CD82 decreases Rac1 expression and cell proliferation through PI3K/Akt/mTOR pathway in H1299 lung carcinoma cells. Cell Biochem Function 2009; 27: 40-47.
13. van der Horst EH, Degenhardt YY, Strelow A, et al. Metastatic properties and genomic amplification of the tyrosine kinase gene ACK1. Proc Natl Acad Sci USA 2005; 102: 15901-15906.